U.S. flag

An official website of the United States government

NC_000002.12:g.(?_44280696)_(44346410_?)del AND Myasthenic syndrome, congenital, 22

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 6, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001390053.2

Allele description [Variation Report for NC_000002.12:g.(?_44280696)_(44346410_?)del]

NC_000002.12:g.(?_44280696)_(44346410_?)del

Genes:
PREPL:prolyl endopeptidase like [Gene - OMIM - HGNC]
SLC3A1:solute carrier family 3 member 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NC_000002.12:g.(?_44280696)_(44346410_?)del
HGVS:
  • NC_000002.12:g.(?_44280696)_(44346410_?)del
  • NC_000002.11:g.(?_44507835)_(44573549_?)del

Condition(s)

Name:
Myasthenic syndrome, congenital, 22 (CMS22)
Synonyms:
PREPL DEFICIENCY
Identifiers:
MONDO: MONDO:0044299; MedGen: C4479088; OMIM: 616224

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001591640Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 6, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Two novel deletions in hypotonia-cystinuria syndrome.

Régal L, Aydin HI, Dieltjens AM, Van Esch H, Francois I, Okur I, Zeybek C, Meulemans S, Van Mol C, Van Bruwaene L, Then SH, Jaeken J, Creemers J.

Mol Genet Metab. 2012 Nov;107(3):614-6. doi: 10.1016/j.ymgme.2012.06.011. Epub 2012 Jun 26.

PubMed [citation]
PMID:
22796000

PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.

Régal L, Shen XM, Selcen D, Verhille C, Meulemans S, Creemers JW, Engel AG.

Neurology. 2014 Apr 8;82(14):1254-60. doi: 10.1212/WNL.0000000000000295. Epub 2014 Mar 7.

PubMed [citation]
PMID:
24610330
PMCID:
PMC4001208
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001591640.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This variant is a gross deletion of the genomic region encompassing exons 2-14 of the PREPL gene. The 5' boundary is likely confined to intron 1. If SLC3A1 has been tested and no copy number events are reported for it, then the 3' boundary of this event lies between the PREPL and SLC3A1 genes. If SLC3A1 has not been tested, the 3' end of this event is unknown as it extends beyond the assayed region of this test and may encompass additional genes including the SLC3A1 gene. This is expected to result in an absent or disrupted protein product. Isolated deletions of exons 2-14 of PREPL have not been reported in the literature. However, larger copy number events that include this region have been reported in individuals affected with hypotonia-cystinuria syndrome (PMID: 24610330, 22796000, 24610330). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024